Sunday, February 8, 2009

F317 MUTATIONS IN CML

  1. Encountered in subjects with CML resistant to Dasatinib
  2. Sensitive eto other TKI
  3. Prognosis depends on the stage

(Blood-2008:112-4839-4852)

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)